Content about Bristol

March 25, 2011
FDA approves Bristol's cancer drug

The Food and Drug Administration has approved a new treatment for late-stage skin cancer, the agency said Friday.

March 24, 2011
Bristol: Ipilimumab boosts survival rates among patients in phase-3 trial

Bristol-Myers Squibb said its late-stage clinical trial for a cancer treatment, which currently is under review by the Food and Drug Administration, achieved its primary endpoint.

March 7, 2011
Bristol-Myers Squibb, WuXi to open testing facility

Drug maker Bristol-Myers Squibb is opening a new testing facility in China under collaboration with a local company there, Bristol said Monday.

February 14, 2011
Study: Bristol's apixaban effective among atrial fibrillation patients

An investigational drug made by Bristol-Myers Squibb works better than aspirin in reducing the risk of complications in certain patients with heart rhythm problems, according to results of a late-stage clinical trial published in the New England Journal of Medicine.

January 31, 2011
Pfizer: Tender offer for King completed

Pfizer has completed its tender offer for Bristol, Tenn.-based King Pharmaceuticals, Pfizer said Monday.

January 21, 2011
Pfizer extends tender offer for King

Pfizer again has extended the expiration date on its tender offer to buy Bristol, Tenn.-based King Pharmaceuticals to Jan. 28, the drug maker said Friday.

December 20, 2010
King, Acura seek regulatory approval for Acurox

Drug makers King Pharmaceuticals and Acura Pharmaceuticals have submitted a regulatory approval application to the Food and Drug Administration for an opioid pain reliever.

December 7, 2010
Bristol-Myers Squibb seeks additional approval for Orencia

The Food and Drug Administration has accepted for review a supplemental approval application for an arthritis drug made by Bristol-Myers Squibb, the drug maker said Monday.

November 22, 2010
Dr. Reddy's to buy GSK's penicillin site

A generic drug maker has entered an agreement to purchase another drug maker's U.S. penicillin site ...

November 7, 2010
RA patients may benefit from weekly injection of Orencia, study finds

Patients with rheumatoid arthritis derive about as much benefit from a weekly injection of a...

October 11, 2010
Pfizer to acquire King Pharmaceuticals

Pfizer will buy King Pharmaceuticals for $3.6 billion, Pfizer said Tuesday....

September 27, 2010
Waiting period for Bristol-ZymoGenetics deal expires

The Hart-Scott-Rodino waiting period for Bristol-Myers Squibb’s acquisition of Seattle-based biotech company ZymoGenetics has expired,...

September 23, 2010
AstraZeneca-Bristol drug just as effective as generic on market, trial results show

An investigational diabetes drug works as well as a generic already on the market, according...

September 7, 2010
Bristol-Myers Squibb to acquire ZymoGenetics

Bristol-Myers Squibb will acquire Seattle-based biotech ZymoGenetics, Bristol said Wednesday....

August 29, 2010
King names new chief commercial officer

Jeffrey Bailey has been appointed as King Pharmaceuticals' chief commercial officer, leading all sales, marketing,...

August 17, 2010
FDA grants priority review for Bristol-Myer Squibb's skin cancer treatment

The Food and Drug Administration has agreed to expedite review of an investigational treatment for...

March 2, 2010
FDA issues complete response letter to Bristol-Myers Squibb

The Food and Drug Administration has declined to approve a biotech drug for organ transplant...

© 2013 Drug Store News. All Rights Reserved.